Identification of potential vaccine candidates against Streptococcus pneumoniae by reverse vaccinology approach

Applied Biochemistry and Biotechnology

Volumn 172, Issue 6, 2014, Pages 3026-3041

  Talukdar, Sandipan ^a   Zutshi, Shubhranshu ^b   Prashanth, K S ^b   Saikia, Kandarpa K ^a   Kumar, Parveen ^b  

^a GAUHATI UNIVERSITY   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Antigens; Immunogenic; pavB; Pullulanase; S. pneumoniae; Vaccine

Indexed keywords

ANTIGENS; EPITOPES; PROTEINS;

IMMUNOGENIC; PAVB; PULLULANASE; REVERSE VACCINOLOGY; S. PNEUMONIAE; STREPTOCOCCUS PNEUMONIAE; SUBCELLULAR LOCALIZATIONS; VACCINE DEVELOPMENT;

VACCINES;

AUTOLYSIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CELL SURFACE PROTEIN; CHOLINE; EPITOPE; FRUCTOSE BISPHOSPHATE ALDOLASE; HYALURONIDASE; LIPOPROTEIN; METALLOPROTEINASE; PHOSPHOGLUCONATE DEHYDROGENASE; PNEUMOCOCCUS VACCINE; PROTEINASE; PROTEOME; PULLULANASE; SIALIDASE; SIGNAL PEPTIDE; STREPTOKINASE; VIRULENCE FACTOR;

AMINO ACID SEQUENCE; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BACTERIAL VIRULENCE; CELLULAR DISTRIBUTION; COMPUTER PROGRAM; DNA SEQUENCE; GRAM POSITIVE BACTERIUM; IMMUNOGENICITY; MACROMOLECULE; MOLECULE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; RATING SCALE; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINE PRODUCTION;

STREPTOCOCCUS PNEUMONIAE;

AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; B-LYMPHOCYTES; BACTERIAL PROTEINS; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; EPITOPES, B-LYMPHOCYTE; GENOME, BACTERIAL; GLYCOSIDE HYDROLASES; HUMANS; MOLECULAR SEQUENCE DATA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROTEOME; STREPTOCOCCUS PNEUMONIAE; VIRULENCE FACTORS;

EID: 84899493964     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-014-0749-x     Document Type: Article

References (42)

1. Ogunniyi, A. D., Grabowicz, M., Briles, D. E., Cook, J., & Paton, J. C. (2007). Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infection and Immunity, 75, 350-357. (Pubitemid 46047911)
2. Jenkins, S. G., Brown, S. D., & Farrell, D. J. (2008). Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA. Annals of Clinical Microbiology and Antimicrobials, 7, 1-11.
3. Eng, J. V., Marcus, R., Hadler, J. L., Imhoff, B., Vugia, D. J., Cieslak, P. R., et al. (2003). Consumer attitudes and use of antibiotics. Emerging Infectious Diseases, 9, 1128-1135. (Pubitemid 37071556)
4. Ceppa, L.L.P. (2012). Lessons learnt from the Accelerated Vaccine Introduction (AVI) project, GAVI alliance. Available from: http://www. gavialliance.org/results/evaluations/avi-project-review/. Accessed July 7, 2012.
5. Todar, K. (2003). In Todar's online textbook of bacteriology: Streptococcus pneumoniae: pneumonia, otitis media and meningitis, available from http://textbookofbacteriology.net/S.pneumoniae.html. Accessed July 9, 2012.
6. Weinberger, D. M., Malley, R., & Lipsitch, M. (2011). Serotype replacement in disease after pneumococcal vaccination. Lancet, 378, 1962-1973.
7. Moyo, S. J., Steinbakk, M., Aboud, S., Mkopi, N., Kasubi, M., Blomberg, B., et al. (2012). Penicillin resistance and serotype distribution of Streptococcus pneumoniae in nasopharyngeal carrier children under-5 years in Dar es Salaam, Tanzania. Journal of Medical Microbiology, 61, 952-959.
8. Jedrzejas, M. J. (2001). Pneumococcal virulence factors: structure and function. Microbiology and Molecular Biology Reviews, 65, 187-207.
9. Kelly, D. F., & Rappuoli, R. (2004). Reverse vaccinology and vaccines for serogroup B Neisseria meningitides. Advances in Experimental Medicine and Biology, 568, 217-223. (Pubitemid 43779680)
10. Capecchi, B., Serruto, D., Adu- Bobie, J., Rappuoli, R., & Pizza, M. (2004). The genome revolution in vaccine research. Current Issues in Molecular Biology, 6, 17-28. (Pubitemid 37441571)
11. Yu, N. Y., Wagner, J. R., Laird, M. R., Melli, G., Rey, S., Lo, R., et al. (2010). PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics, 26, 1608-1615.
12. McGinnis, S., & Thomas, L. M. (2004). BLAST: at the core of a powerful and diverse set of sequence analysis tools. Nucleic Acids Research, 32, W20-W25. (Pubitemid 38997292)
13. Wheeler, D. L., Barrett, T., Benson, D. A., Bryant, S. H., & Canese, K. (2006). Databases resources of the National Center for Biotechnology Information. Nucleic Acids Research, 34, D173-D180.
14. Sayers, E. W., Barrett, T., Benson, D. A., Bryant, S. H., Canese, K., Chetvernin, V., et al. (2009). Databases resources for the National Center for Biotechnology Information. Nucleic Acids Research, 37, D5-D15.
15. Kolaskar, A. S., & Tongaonkar, P. C. (1990). A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Letters, 276, 172-174.
16. Sharma, P., & Bezbaruah, R. L. (2011). Antigenic site detection of the spike protein and designing of a vaccine candidate against SARS coronavirus using reverse vaccinology: an in silico approach. International Journal of Pharmacy and Technology, 3, 3555-3568.
17. Serruto, D., Serino, L., Masignani, V., & Pizza, M. (2009). Genome-based approaches to develop vaccines against bacterial pathogens. Vaccine, 27, 3245-3250.
18. Maione, D., Margarit, I., Rinaudo, C. D., Masignani, V., Mora, M., Scarselli, M., et al. (2005). Identification of a universal group B streptococcus vaccine by multiple genome screen. Science, 309, 148-150. (Pubitemid 40934997)
19. Wizemann, T. M., Heinrichs, J. H., Adamou, J. E., Erwin, A. L., Kunsch, C., Choi, G. H., et al. (2001). Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infection and Immunity, 69, 1593-1598. (Pubitemid 32187614)
20. Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., et al. (2000). Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science, 287, 1816-1820.
21. Giuliani, M. M., Adu-Bobie, J., Comanducci, M., Arico, B., Savino, S., Santini, L., et al. (2006). A universal vaccine for serogroup B meningococcus. Proceedings of the National Academy of Sciences, 103, 10834-10839. (Pubitemid 44148381)
22. Toneatto, D., Ismaili, S., Ypma, E., Vienken, K., Oster, P., & Dull, P. (2011). The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans. Human Vaccines & Immunotherapeutics, 7, 646-653.
23. John, L., John, G. G., & Kholia, T. (2012). A reverse vaccinology approach for the identification of potential vaccine candidates from Leishmania spp. Applied Biochemistry and Biotechnology, 167, 1340-1350.
24. de Oliveira Lopes, D., de Oliveira, F. M., do Vale Coelho, I. E., de Oliveira Santana, K. T., Mendonça, F. C., Taranto, A. G., et al. (2013). Identification of a vaccine against schistosomiasis using bioinformatics and molecular modeling tools. Infection, Genetics and Evolution, 20, 83-95. doi:10.1016/j.meegid.2013.08.007.
25. Oprea, M., & Antohe, F. (2013). Reverse-vaccinology strategy for designing T-cell epitope candidates for Staphylococcus aureus endocarditis vaccine. Biologicals, 41, 148-153. doi:10.1016/j.biologicals.2013.03.001.
26. Shen, H. B., & Chou, K. C. (2010). Virus-mPLoc: a fusion classifier for viral protein subcellular location prediction by incorporating multiple sites. Journal of Biomolecular Structure and Dynamics, 28, 175-186.
27. Shen, H. B., & Chou, K. C. (2007). Virus-PLoc: a fusion classifier for predicting the subcellular localization of viral proteins within host and virus-infected cells. Biopolymers, 85, 233-240.
28. Lu, Z., Szafron, D., Greiner, R., Lu, P., Wishart, D. S., Poulin, B., et al. (2004). Predicting subcellular localization of proteins using machine-learned classifiers. Bioinformatics, 20, 547-556. (Pubitemid 38344335)
29. Mooney, C., Wang, Y. H., & Pollastri, G. (2011). SCLpred: protein subcellular localization prediction by N-to-1 neural networks. Bioinformatics, 27, 2812-2819.
30. Ferreira, D. M., Darrieux, M., Silva, D. A., Leite, L. C., Ferreira, J. M., Jr., Ho, P. L., et al. (2009). Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein pspA & pspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clinical and Vaccine Immunology, 16, 636-645.
31. Mizrachi, N. Y., Ling, E., Feldman, G., Portnoi, M., Dagan, R., Overweg, K., et al. (2004). Glycolytic enzymes associated with cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clinical and Experimental Immunology, 138, 290-298. (Pubitemid 39472446)
32. Gosink, K., Mann, E. R., Guglielmo, C., Tuomanen, E. I., & Masure, H. R. (2000). Role of novel choline binding proteins in virulence of Streptococcus pneumoniae. Infection and Immunity, 68, 5690-5695.
33. Zhang, Y., Masi, A. W., Barniak, V., Mountzouros, K., Hostetter, M. K., & Green, B. A. (2001). Recombinant phpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge. Infection and Immunity, 69, 3827-3836. (Pubitemid 32493302)
34. Jedrzejas, M. J. (2007). Unveiling molecular mechanisms of bacterial surface proteins: Streptococcus pneumoniae as a model organism for structural studies. Cellular and Molecular Life Sciences, 64, 2799-2822.
35. Bumbaca, D., Littlejohn, J. E., Nayakanti, H., Rigden, D. J., Galperin, M. Y., & Jedrzejas, M. J. (2004). Sequence analysis and characterization of a novel fibronectin-binding repeat domain from the surface of Streptococcus pneumoniae. OMICS, 8, 341-356. (Pubitemid 40250751)
36. Paterson, G. K., & Orihuela, C. J. (2010). Pneumococcal microbial surface components recognizing adhesive matrix molecules targeting of the extracellular matrix. Molecular Microbiology, 77, 1-5.
37. Jensch, I., Gamez, G., Rothe, M., Ebert, S., Fulde, M., Somplatzki, D., et al. (2010). PavB is a surface-exposed adhesion of Streptococcus pneumoniae contributing to nasopharyngeal colonization and airways infections. Molecular Microbiology, 77, 22-43.
38. Hatada, Y., Igarashi, K., Ozaki, K., Ara, K., Hitomi, J., Kobayashi, T., et al. (1996). Amino acid sequence and molecular structure of an alkaline amylopullulanase from bacillus that hydrolyzes alpha-1,4 and alpha-1, 6 linkages in polysaccharides at different active sites. Journal of Biological Chemistry, 271, 24075-24083.
39. Bongaerts, R. J., Heinz, H. P., Hadding, U., & Zysk, G. (2000). Antigenicity, expression, and molecular characterization of surface-located pullulanase of Streptococcus pneumoniae. Infection and Immunity, 68, 7141-7143. (Pubitemid 32463431)
40. Albertson, G. D., McHale, R. H., Gibbs, M. D., & Bergquist, P. L. (1997). Cloning and sequence of a type I pullulanase from an extremely thermophilic anaerobic bacterium, Caldicellulosiruptor saccharolyticus. Biochimica et Biophysica Acta, 1354, 35-39. (Pubitemid 27479890)
41. van Bueren, A. L., Higgins, M., Wang, D., Burke, R. D., & Boraston, A. B. (2007). Identification and structural basis of binding to host lung glycogen by streptococcal virulence factors. Nature Structural and Molecular Biology, 14, 76-84. (Pubitemid 46067426)
42. Abbott, D. W., Higgins, M. A., Hyrnuik, S., Pluvinage, B., Lammerts van Bueren, A., & Boraston, A. B. (2010). The molecular basis of glycogen breakdown and transport in Streptococcus pneumoniae. Molecular Microbiology, 77, 183-199.